Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases by Catherine E. Raptis, Christoph T. Berger, Christoph T. Berger, Adrian Ciurea, Diego O. Andrey, Diego O. Andrey, Christos Polysopoulos, Pierre Lescuyer, Tanja Maletic, Myriam Riek, Almut Scherer, Isabell von Loga, Judith Safford, Kim Lauper, Kim Lauper, Burkhard Möller, Nicolas Vuilleumier, Nicolas Vuilleumier, Axel Finckh, Axel Finckh, Andrea Rubbert-Roth

Get full text